# Aspire Fertility Institute Dallas – FDA Inspection, Jul 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/aspire-fertility-institute-dallas/82b3eed2-1011-4416-a134-4aaacb04a2f2
Source feed: FDA_Inspections

> FDA inspection 1210012 of Aspire Fertility Institute Dallas, July 12, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 1271. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210012
- Company Name: Aspire Fertility Institute Dallas
- Inspection Date: 2023-07-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1259652 - 2025-01-23
- FDA Inspection 1064726 - 2018-08-22

## Related Officers

- [Bobbi J. Miller](https://www.keypedia.com/people/bobbi-j-miller/e005d16b-d354-4447-8e58-d540b0710467)

Company: https://www.keypedia.com/companies/aspire-fertility-institute-dallas/6cdc8d6b-1dcf-4e4d-b543-4a4f66be1c65

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d